UCR 037: E&M 2021 Risk - is prostate cancer with watchful waiting a level 2,3,4 or 5?
February 5, 2021
Mark, Ray, and Scott discuss Risk under the new E&M 2021 guidelines. Mark lays out a position that you can have a level 2, 3, 4, and 5 for watchful waiting for patients with prostate cancer. Your documentation is the key.
You need to provide the complete picture to include clinical and medical reimbursement perspectives.
Take the 30 Day "Code like Mark Painter" Challenge and finally master urology coding.
Join the discussion:
Urology Coding and Reimbursement Group - Join for free and ask your questions, and share your wisdom.